Horse erythrocyte factor enhancing sulphonamide activity. I. Partial purification and data on the mode of action.

1. Keilin D, Mann T. Carbonic anhydrase. Purification and nature of the enzyme.. Biochem J 1940 Sep;34(8-9):1163-76.
   pubmed: 16747299doi: 10.1042/bj0341163google scholar: lookup
2. HAUT A, CARTWRIGHT GE, WINTROBE MM. ELECTROPHORESIS OF NONHEMOGLOBIN PROTEINS FROM CONCENTRATED HEMOGLOBIN-FREE HEMOLYSATES.. J Lab Clin Med 1964 Feb;63:279-89.
   pubmed: 14125114
3. BIGGER JW, WARE GC. Potentiation of sulphonamide by "L substance.".. Lancet 1950 Sep 30;2(6631):427-33.
   pubmed: 14785178doi: 10.1016/s0140-6736(50)91382-1google scholar: lookup
4. ADAMS E, SMITH EL. Peptidases of erythrocytes. II. Isolation and properties of prolidase.. J Biol Chem 1952 Oct;198(2):671-82.
   pubmed: 12999784
5. DRABKIN DL. Spectrophotometric studies; the crystallographic and optical properties of the hemoglobin of man in comparison with those of other species.. J Biol Chem 1946 Aug;164(2):703-23.
   pubmed: 21001166
6. WALKER N, PHILIP RP. Observations on the prevention of bacterial growth by sulphonamides, with special reference to the Harper and Cawston effect.. J Pathol Bacteriol 1947 Oct;59(4):631-45.
   pubmed: 18907571doi: 10.1002/path.1700590413google scholar: lookup
7. Bushby SR. Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.. Postgrad Med J 1969 Nov;45:Suppl:10-8.
   pubmed: 5361305
8. Waterworth PM. Practical aspects of testing sensitivity to trimethoprim and sulphonamide.. Postgrad Med J 1969 Nov;45:Suppl:21-9.
   pubmed: 4902846
9. Bushby SR, Hitchings GH. Trimethoprim, a sulphonamide potentiator.. Br J Pharmacol Chemother 1968 May;33(1):72-90.
   pubmed: 5301731doi: 10.1111/j.1476-5381.1968.tb00475.xgoogle scholar: lookup
10. HUENNEKENS FM, CAFFREY RW, BASFORD RE, GABRIO BW. Erythrocyte metabolism. IV. Isolation and properties of methemoglobin reductase.. J Biol Chem 1957 Jul;227(1):261-72.
    pubmed: 13449071
11. Böhni E. [Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo].. Chemotherapy 1969;14:Suppl:1-21.
    pubmed: 4908562
12. CHABBERT Y, BOYER F, DECHAVASSINE M. [Determination of bacterial sensitivity to sulfonamides by dry-disk method].. Ann Inst Pasteur (Paris) 1953 Jul;85(1):56-63.
    pubmed: 13148720
13. LUND E. Sensitivity testing with sulphonamide preparations.. Acta Pathol Microbiol Scand 1955;36(5):431-2.
    pubmed: 14398247doi: 10.1111/j.1699-0463.1955.tb04637.xgoogle scholar: lookup

Citations

1. Ferone R, Bushby SR, Burchall JJ, Moore WD, Smith D. Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.. Antimicrob Agents Chemother 1975 Jan;7(1):91-8.
   doi: 10.1128/AAC.7.1.91pubmed: 1169907google scholar: lookup